IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2009
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2413

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.08-2413v1
50/1/378    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petropoulos, I. K.
Right arrow Articles by Pournaras, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petropoulos, I. K.
Right arrow Articles by Pournaras, C. J.

Article

Effect of Systemic Nitric Oxide Synthase Inhibition on Optic Disc Oxygen Partial Pressure in Normoxia and in Hypercapnia

Ioannis K. Petropoulos 1, Jean-Antoine C. Pournaras 2, Alexandros N. Stangos 1, and Constantin J. Pournaras 3*

1 Department of Ophthalmology, University Hospital of Geneva, Geneva, Switzerland
2 Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
3 Department of Ophthalmology, University Hospital of Geneva, Rue Alcide-Jentzer 22, Geneva, 1211 GE 14, Switzerland

* To whom correspondence should be addressed. E-mail: constantin.pournaras{at}hcuge.ch.


   Abstract

PURPOSE. To investigate the effect of systemic nitric oxide synthase (NOS) inhibition on optic disc oxygen partial pressure (PO2) in normoxia and hypercapnia. METHODS. We measured intervascular optic disc PO2 in 12 anesthetized minipigs using oxygen-sensitive microelectrodes placed <50 µm from the optic disc. PO2 was measured continuously during 10 minutes under normoxia, hyperoxia (100% O2), carbogen breathing (95% O2, 5% CO2), and hypercapnia (increased inhaled CO2). Measurements were repeated after intravenous injection of N{omega}-nitro-L-arginine methyl ester (L-NAME) 100 mg/kg. Intravenous L-arginine 100 mg/kg was subsequently given to three animals. RESULTS. Before L-NAME injection, we observed an increase in optic disc PO2 during hypercapnia ({Delta}PO2 = 3.2 ± 1.7 mm Hg; 18%; P = 0.001) and carbogen breathing ({Delta}PO2 = 12.8 ± 5.1 mm Hg; 69%; P < 0.001). Optic disc PO2 in normoxia remained stable during 30 minutes following L-NAME injection (4% decrease from baseline; P > 0.1) despite a 21% increase of mean arterial pressure. Optic disc PO2 increase under hypercapnia was blunted following L-NAME injection ({Delta}PO2 = 0.6 ± 1.1 mm Hg; 3%; P > 0.1), and this effect was reversible by L-arginine. Moreover, L-NAME reduced the response to carbogen by 29% ({Delta}PO2 = 9.1 ± 4.4 mm Hg; 49%; P = 0.01 versus before L-NAME). The response to hyperoxia was not affected. CONCLUSIONS. While systemic NOS inhibition did not affect optic disc PO2 in normoxia, a blunting effect was noted on CO2-induced optic disc PO2 increase. Nitric oxide appears to mediate hypercapnic optic disc PO2 increase.

Key Words: optic disc, nitric oxide, oxygen partial pressure, carbon dioxide, L-NAME, hypercapnia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology